Keywords: ایمی کیمود; 5FU; fluorouracil 5%; CMOBC; cutaneous metastases of breast cancer; MBC; metastatic breast cancer; TLR7; toll-like receptor 7; antitumor immunity; breast cancer; cryotherapy; cutaneous metastases; fluorouracil; imiquimod; in situ vaccination; skin-direct
مقالات ISI ایمی کیمود (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمی کیمود; IMQ; imiquimod; KO; knockout;
Keywords: ایمی کیمود; 5-fluorouracil; imiquimod; ingenol mebutate; acitretin; American Joint Commission on Cancer; Brigham and Women's Hospital staging system; capecitabine; CDKN2A; cetuximab; chemotherapy; classification; cSCC; CT; cutaneous squamous cell carcinoma; familial
Keywords: ایمی کیمود; Imiquimod; Hemangioma; Endothelium; Cytotoxicity;
Keywords: ایمی کیمود; SC; subcutaneous; OA-NO2; nitro oleic acid; ACD; allergic contact dermatitis; CHS; contact hypersensitivity; LNO2; nitro linoleic acid; CLA-NO2; conjugated nitro linoleic acid; PPAR-γ; peroxisome proliferator-activated receptor-γ; Nrf2; nuclear factor E
Keywords: ایمی کیمود; CXCL; CXC chemokine ligand; CM; conditioned medium; IMQ; imiquimod; LN; lymph node; WT; wild-type;
Keywords: ایمی کیمود; IMQ; imiquimod; TLR; toll-like receptor;
Keywords: ایمی کیمود; Brimonidine; calcineurin inhibitors; corticosteroids; creams; imiquimod; ingenol mebutate; ivermectin; ointments; rapamycin; retapamulin; retinoids; topical treatments; vitamin D analogues;
Keywords: ایمی کیمود; Imiquimod; Periocular tumors; Basal cell carcinoma; Topical treatment; Unfavorable cases; Imiquimod; Tumores perioculares; Carcinoma basocelular; Tratamiento tópico; Casos desfavorables;
Keywords: ایمی کیمود; AD; atopic dermatitis; α2HS-GP; alpha-2-HS-glycoprotein; CCL20; C-C motif ligand 20; CCR2; C-C chemokine receptor type 2; CRP; C-reactive protein; CYA; ciclosporin; DC; dendritic cells; Dkk-1; dickkopf-related protein 1; dMVECs; dermal microvascular
Keywords: ایمی کیمود; APC; antigen presenting cell; DLS; dynamic light scattering; PFA; paraformaldehyde; COX; cycloxygenase; LOX; lipoxygenase; LPS; lipo poly saccharide; FBS; fetal bovine serum; IMQ; imiquimod; SOD; superoxide dismutase; MDA; malon di-aldehyde; GSH; glutathi
Keywords: ایمی کیمود; ASC; adipose-derived stromal cell; IMQ; imiquimod; FBs; fibroblasts; MSC; mesenchymal stem cell; BM; bone marrow;
Keywords: ایمی کیمود; Extramammary Paget's disease; Imiquimod; Vulvar cancer
Keywords: ایمی کیمود; Sensory nerves; Transient receptor potential channels; Neuropeptides; Skin inflammation; Peripheral vasculature; ATP; adenosine triphosphate; CFA; Complete Freund's Adjuvant; CGRP; calcitonin gene related peptide; CLR; calcitonin receptor-like receptor; C
Keywords: ایمی کیمود; BDCA-2; blood dendritic cell antigen-2; CD123; interleukin-3 receptor α chain; CTL; cytotoxic CD8 T lymphocyte; DC; dendritic cell; GZMB; granzyme B; IFN; interferon; IL; interleukin; ILT7; immunoglobulin superfamily receptor immunoglobulin-like transcri
Keywords: ایمی کیمود; efficacy; follow-up; imiquimod; lentigo maligna; prognostic marker; recurrence; topical immunomodulators;
Keywords: ایمی کیمود; Psoriasis; Imiquimod; Acarbose; Inflammation; Tr1 T cells; IL-10
Keywords: ایمی کیمود; Herpes simplex genitalis; Atypical manifestation; Hypertrophic type; HIV infection; Imiquimod
Keywords: ایمی کیمود; imiquimod; lentigo maligna; melanoma; CI; confidence interval; LM; lentigo maligna; OR; odds ratio;
Keywords: ایمی کیمود; Epidermis; Hyperplasia; Imiquimod; Periostin; Psoriasis
Keywords: ایمی کیمود; clinical response; extramammary Paget disease of the vulva; imiquimod; tissue-sparing surgery; treatment of recurrences; CR; complete response; EMPD; extramammary Paget disease; PR; partial response;
Keywords: ایمی کیمود; Basal cell carcinoma; Imiquimod; Cancerization field; Risk; Cutaneous neoplasm; Second primary.Carcinoma basocelular; Imiquimod; Campo de cancerización; Riesgo; Neoplasia cutánea; Segundo primario.
Keywords: ایمی کیمود; actinic keratosis; basal cell carcinoma; Bowen disease; erythroplasia of Queyrat; lentigo maligna; melanoma; Paget disease; skin cancer; squamous cell carcinoma; topical treatment; 5-FU; 5-fluorouracil; AK; actinic keratosis; BCC; basal cell carcinoma; B
Keywords: ایمی کیمود; vulvar intraepithelial neoplasia; Bowen’s disease; squamous cell carcinoma in situ; imiquimod
Keywords: ایمی کیمود; Basal cell carcinoma; Cryosurgery; Dermatologic surgery; Elderly; Electrodessication and curettage; Imiquimod; Life expectancy; Mohs surgery; Nonmelanoma skin cancer; Photodynamic therapy; Vismodegib
Sulfoximines as potent RORγ inverse agonists
Keywords: ایمی کیمود; RORγ; Sulfoximine; Psoriasis; Imiquimod; Topical application; OZSLLZRELNMFLA-XIFFEERXSA-N;
Tratamiento con imiquimod al 5% durante 12 dÃas para las queratosis actÃnicas: estudio de la eficacia y la reacción local
Keywords: ایمی کیمود; Imiquimod; Queratosis actÃnicas; Tratamiento; Reacción local; Imiquimod; Actinic keratosis; Treatment; Local reaction;
Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice
Keywords: ایمی کیمود; Aromatic-turmerone; Psoriasis; Anti-inflammation; Proinflammatory cytokines; Imiquimod;
Pharmacokinetics and pharmacodynamics of intravesical and intravenous TMX-101 and TMX-202 in a F344 rat model
Keywords: ایمی کیمود; Immune modulator; Imiquimod; Non-muscle-invasive bladder cancer; Pharmacodynamics; Pharmacokinetics; Toll-like receptor;
Successful treatment of giant invasive cutaneous squamous cell carcinoma by plum-blossom needle assisted photodynamic therapy sequential with imiquimod: Case experience
Keywords: ایمی کیمود; Invasive cutaneous squamous cell carcinoma; Plum-blossom needle; Photodynamic therapy; Imiquimod;
Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes
Keywords: ایمی کیمود; Psoriasis; Sunitinib; Imiquimod; Hacat cells; Stat3;
Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice
Keywords: ایمی کیمود; Psoriasis; Imiquimod; Tetrathiomolybdate; Copper;
How Effective Is Tacrolimus in the Imiquimod-Induced Mouse Model of Psoriasis?
Keywords: ایمی کیمود; IMQ; imiquimod; TAC; tacrolimus;
Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model
Keywords: ایمی کیمود; DCs; dendritic cells; dDCs; dermal dendritic cells; DT; diphtheria toxin; DTA; diphtheria toxin subunit A; DTR; diphtheria toxin receptor; huLangerin; human Langerin; IMQ; imiquimod; LCs; Langerhans cells; mLCs; monocyte-derived Langerhans cells; rLCs; re
The expression of mCTLA-4 in skin lesion inversely correlates with the severity of psoriasis
Keywords: ایمی کیمود; CTLA4; Cytotoxic T lymphocyte antigen-4; sCTLA-4; soluble Cytotoxic T lymphocyte antigen-4; mCTLA-4; membrane Cytotoxic T lymphocyte antigen-4; IOD; Integrated option density; IMQ; Imiquimod; PASI; psoriasis area and severity index; Treg; regulatory T; CT
Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma
Keywords: ایمی کیمود; Imiquimod; Dendritic cell vaccine; Tumor immunotherapy; Regulatory T cells (Treg); Mast cells;
Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways
Keywords: ایمی کیمود; Resolvin D1; Keratinocyte; Psoriasis; Inflammation; MAPKs; Boc; tert-butoxycarbonyl Met-Leu-Phe peptide; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; IL-17; interleukin-17; IL-22; interleukin-22; IL-23; interleukin-23; IMQ; imiquimod; MAPKs; mitogen-a
Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17
Keywords: ایمی کیمود; SAHH; S-adenosyl-l-homocysteine hydrolase; IMQ; imiquimod; KC; keratinocytes; IL; interleukin; ICAM-1; intercellular adhesion molecule-1; EGFR; epidermal growth factor receptor; MAPKs; mitogen activated protein kinases; ERK; extracellular signal-regulated
Diarylheptanoid from rhizomes of Curcuma kwangsiensis (DCK) inhibited imiquimod-induced dendritic cells activation and Th1/Th17 differentiation
Keywords: ایمی کیمود; APCs; antigen presenting cells; CCL; chemokine (CC motif) ligand; CCR; CC chemokine receptor type; DAPI; 40,6-diamidino-2-phenylindole; DCK; diarylheptanoid from Curcuma kwangsiensis; DCs; dendritic cells; ERK; extracellular signal-regulated kinase; GM-CS
Topically applied azaphenothiazines inhibit experimental psoriasis in mice
Keywords: ایمی کیمود; TNF α; tumor necrosis factor α; IL; interleukin; LPS; lipopolysaccharide; IMQ; imiquimod; KERTr; human skin keratinocyte cell line; CXCL; C-X-C motif ligand; poly(I:C); polyinosinic:polycytidylic acid; LF; lipofectamine; Psoriasis; Mice; Azaphenothiazin
Regnase-1, an Immunomodulator, Limits the IL-36/IL-36R Autostimulatory Loop in Keratinocytes to Suppress Skin Inflammation
Keywords: ایمی کیمود; CH; contact hypersensitivity; IL-36R; IL-36 receptor; KC; keratinocyte; KD; knock-down; KO; knock-out; IMQ; imiquimod; Reg1; regnase-1;
Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma
Keywords: ایمی کیمود; Squamous cell carcinoma; Imiquimod; ALA-PDT; Immunohistochemistry; q PCR; Apoptosis;
Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression
Keywords: ایمی کیمود; GAL; galanin; GAL2-KO; GAL2-R knockout mouse; GAL3-KO; GAL3-R knockout mouse; GAL2-R; galanin receptor 2; GAL3-R; galanin receptor 3; IMQ; imiquimod; KO; knockout; MPO; myeloperoxidase; TNF-α; tumor necrosis factor-α; WT; wild-type;
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis
Keywords: ایمی کیمود; IMQ; imiquimod; Th; T helper;
TRPA1 Acts in a Protective Manner in Imiquimod-Induced Psoriasiform Dermatitis in Mice
Keywords: ایمی کیمود; IMQ; imiquimod; KO; knockout; RTX; resiniferatoxin; TNF-α; tumor necrosis factor-α; TLR; toll-like receptor; TRPA1; transient receptor potential ankyrin 1; TRPV1; transient receptor potential vanilloid 1; WT; wild type;
Exacerbation and Prolongation of Psoriasiform Inflammation in Diabetic Obese Mice: A Synergistic Role of CXCL5 and Endoplasmic Reticulum Stress
Keywords: ایمی کیمود; ER; endoplasmic reticulum; IMQ; imiquimod; PA; palmitic acid;
Skin-Specific CD301b+ Dermal Dendritic Cells Drive IL-17âMediated Psoriasis-Like Immune Response in Mice
Keywords: ایمی کیمود; BM; bone marrow; cDC; conventional dendritic cell; DC; dendritic cell; DT; diphtheria toxin; DTR; diphtheria toxin receptor; FLT3L; FMS-like tyrosine kinase 3 ligand; IMQ; imiquimod; LC; Langerhans cell;
CD100-Plexin-B2 Promotes the Inflammation in Psoriasis by Activating NF-κB and the Inflammasome in Keratinocytes
Keywords: ایمی کیمود; AD; atopic dermatitis; IMQ; imiquimod; mCD100; membrane-bound CD100; qRT-PCR; quantitative real-time reverse transcriptase-PCR; sCD100; soluble CD100; siRNA; small interfering RNA; Th; TÂ helper;
Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects
Keywords: ایمی کیمود; Psoriasis; contact dermatitis; imiquimod; Aldara; plasmacytoid dendritic cell; IL-23; TH17; cytotoxicity; Toll-like receptor; innate immunity; ACD; Allergic contact dermatitis; APC; Allophycocyanin; BDCA2; Blood dendritic cell antigen 2; HRP; Horseradish
Ãruption de kystes épidermiques après application d'imiquimod topique
Keywords: ایمی کیمود; Imiquimod; Carcinome basocellulaire; Kyste épidermique; Milium; Imiquimod; Basal cell carcinoma; Epidermal cyst; Milia;